Syringe Market Size (2024 - 2029)

The syringe market is projected to experience significant growth over the forecast period, driven by factors such as the increasing prevalence of chronic and infectious diseases, the rising adoption of injectable drugs, and technological advancements in syringe design. The market's expansion is further supported by the growth in vaccination and immunization programs and the development of new manufacturing facilities. However, challenges such as the risk of needle-stick injuries, the high cost of safe syringes, and the availability of alternative drug delivery methods may impede the market's growth.

Market Size of Syringe Industry

Syringe Market Summary
Study Period 2021 - 2029
Market Size (2024) USD 18.37 Billion
Market Size (2029) USD 27.85 Billion
CAGR (2024 - 2029) 8.68 %
Fastest Growing Market North America
Largest Market Asia-Pacific

Major Players

Syringe Market Major Players

*Disclaimer: Major Players sorted in no particular order

Syringes Market Analysis

The Syringe Market size is estimated at USD 18.37 billion in 2024, and is expected to reach USD 27.85 billion by 2029, growing at a CAGR of 8.68% during the forecast period (2024-2029).

COVID-19 had a significant impact on the syringe market owing to the rise in the development of vaccines, which led to an increased demand for syringes. Since the outbreak of the pandemic had disrupted the whole healthcare system, the industry faced a shortage of syringes that meet the requirements for the large patient pool. For instance, as per the UN report published in November 2021, based on a scenario in which approximately seven billion people require two doses of coronavirus vaccine over the vaccination period, the UN health agency predicted that a shortage of at least one billion syringes could occur if manufacturing does not improve. However, now that the pandemic's restrictions have been lifted and the spread has been reduced, the market is moving at a slow pace as many companies reduced production of syringes as the vaccination drives reduced. For instance, in October 2022, Hindustan Syringes & Medical Devices (HMD), a manufacturer of disposable syringes and auto-disposable syringes, reduced production of syringes from over 40 lakh per day of AD syringes to 5-6 lakh daily as the government either suspended or rescheduled its orders due to decreased demand for vaccination.

Furthermore, the major factors driving the growth of the syringe market include the growing prevalence of chronic and infectious diseases. As per the International Diabetes Federation 2021 report, the number of people living with diabetes was around 537 million (20-79 years) in the year 2021. Additionally, the number of people living with diabetes is expected to increase from 643 million in 2030 to nearly 783 million by 2045 globally. Most of the diagnostic and therapeutic techniques for chronic diseases require syringes, as these play a vital role during tests and drug administration, and thus the growing burden of diseases is expected to drive the growth of the market.

Moreover, the increased adoption of injectable drugs, technological advancements in syringes, and the growing number of vaccination and immunization programs are expected to drive the volume growth over the next few years. For instance, in January 2022, Nephron Pharmaceuticals Corporation launched the cyclic olefin copolymer syringe (COC). It has a glass-like appearance but is break-resistant and lightweight. COC syringes are suitable for a variety of medications, including highly viscous drugs, and provide an extended product shelf-life. The disconnected plunger allows for easier storage. Also, the expansion of facilities for the production of syringes is anticipated to contribute to the growth of the market. For instance, in June 2022, WuXi Biologics launched the GMP operation of its new drug product facility, DP5, which is located in Wuxi, China. It is a manufacturing facility for the production of vials and pre-filled syringes.

Hence, owing to the rise in chronic diseases, the increase in the adoption of injectable drugs, and technological advances in syringes, the syringe market is expected to witness rapid growth over the forecast period. However, the rise in the incidence of needle-stick injuries, the high cost associated with safe syringes, and the availability of alternate drug delivery methods are likely to hinder the growth of the syringe market globally.

Syringes Industry Segmentation

As per the scope of the report, the syringe is a device used by medical professionals to transfer liquids into or out of the body. It is made up of a hollow needle, which is attached to a tube and a plunger. The Syringe Market is segmented by Usage (Sterilizable/Reusable Syringes, and Disposable Syringes (Conventional Syringes, Safety Syringes, Pre-fillable Syringes), Application (Diabetes, Botox, Osteoarthritis, Human Growth Hormone, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above-mentioned segments.

By Usage
Sterilizable/Reusable Syringes
Disposable Syringes
Conventional Syringes
Safety Syringes
Prefillable Syringes
By Application
Diabetes
Botox
Osteoarthritis
Human Growth Hormone
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Syringe Market Size Summary

The syringe market is poised for significant growth over the forecast period, driven by the increasing prevalence of chronic and infectious diseases, the rising adoption of injectable drugs, and technological advancements in syringe design. The market experienced a surge in demand during the COVID-19 pandemic due to vaccine development, which highlighted the critical role of syringes in healthcare. However, post-pandemic, the market has seen a slowdown as production was scaled back in response to decreased vaccination demands. Despite this, the market is expected to rebound, supported by the ongoing need for syringes in diagnostic and therapeutic applications, particularly for chronic conditions like diabetes. Innovations such as the cyclic olefin copolymer syringe and the expansion of production facilities are anticipated to further bolster market growth.

The pre-fillable syringe segment is expected to witness robust expansion, fueled by the increasing incidence of chronic diseases and advancements in syringe technology. Regulatory approvals, product launches, and strategic collaborations are key factors driving this segment's growth. The Asia-Pacific region is projected to experience healthy market growth due to improving economic conditions, rising awareness of pre-fillable syringes, and a large patient pool. The market is characterized by a high degree of fragmentation, with numerous local and international players employing various strategies such as partnerships, mergers, and new product introductions to enhance their market presence. Recent product approvals and innovations, such as the ready-to-fill polymer syringe and next-generation glass prefillable syringes, are expected to further propel market adoption and growth.

Explore More

Syringe Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Burden of Chronic Diseases and Infectious Diseases

      2. 1.2.2 Increase In the Number of Mass Vaccination Programs

      3. 1.2.3 Rise In the Trend of Self-Administration of Injections Along with Greater Dose Precision Associated with Injections

    3. 1.3 Market Restraints

      1. 1.3.1 Growing Cases of Needle-stick Injuries, Coupled with High Cost of Safety Syringes

      2. 1.3.2 Availability of Alternate Drug Delivery Methods

    4. 1.4 Porter Five Forces

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Usage

      1. 2.1.1 Sterilizable/Reusable Syringes

      2. 2.1.2 Disposable Syringes

        1. 2.1.2.1 Conventional Syringes

        2. 2.1.2.2 Safety Syringes

        3. 2.1.2.3 Prefillable Syringes

    2. 2.2 By Application

      1. 2.2.1 Diabetes

      2. 2.2.2 Botox

      3. 2.2.3 Osteoarthritis

      4. 2.2.4 Human Growth Hormone

      5. 2.2.5 Other Applications

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Syringe Market Size FAQs

The Syringe Market size is expected to reach USD 18.37 billion in 2024 and grow at a CAGR of 8.68% to reach USD 27.85 billion by 2029.

In 2024, the Syringe Market size is expected to reach USD 18.37 billion.

Syringe Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)